Varicella Zoster Virus Antibodies

Santa Cruz Biotechnology offers a broad range of Varicella Zoster Virus monoclonal antibodies for the detection and analysis of the varicella zoster virus (VZV) in research applications. Varicella Zoster Virus Antibodies are essential tools for techniques such as western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). The varicella zoster virus is responsible for causing chickenpox and shingles, making it a significant focus of study in virology and infectious disease research. Understanding the mechanisms of VZV infection and its latency is crucial for developing effective treatments and vaccines. The role of VZV in postherpetic neuralgia and other complications further highlights the importance of studying this virus. Researchers worldwide rely on VZV monoclonal antibodies to investigate viral protein expression, cellular localization, and host-pathogen interactions. Advanced research techniques utilizing VZV monoclonal antibodies help identify potential therapeutic targets and evaluate vaccine efficacy. Santa Cruz Biotechnology monoclonal antibodies for VZV research support scientists in their mission to advance our understanding of viral pathogenesis and develop improved treatments for VZV-related diseases.